Related Experiment Video
Updated: Aug 10, 2026

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
Published on: September 1, 2019
SRC-3/AIB1: transcriptional coactivator in oncogenesis
Jun Yan1, Sophia Y Tsai, Ming-Jer Tsai
1Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, Texas 77030, USA.
Steroid receptor coactivator-3 (SRC-3) is linked to various cancers. Recent findings highlight its causal role in human cancer development and its importance in both hormone-sensitive and -insensitive cancers.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Steroid receptor coactivator-3 (SRC-3) is located on chromosome 20q12, a region frequently amplified in cancers.
- SRC-3 has been associated with the development of breast, gastric, and prostate cancers.
- While previously implicated as an oncogene, recent evidence suggests SRC-3 plays a causal role in human cancer genesis.
Purpose of the Study:
- To summarize recent evidence on the role of SRC-3 in human cancers.
- To highlight the significance of aberrant SRC-3 expression in both hormone-sensitive and hormone-insensitive cancers.
Main Methods:
- Literature review of recent studies on SRC-3 and cancer.
- Analysis of evidence implicating SRC-3 in cancer development.
- Summary of findings related to SRC-3 expression in various cancer types.
Main Results:
- Aberrant SRC-3 expression is increasingly recognized as a critical factor in human cancer.
- SRC-3's role extends to both hormone-sensitive and hormone-insensitive cancer types.
- Compelling evidence now supports SRC-3 as a causal factor in cancer genesis.
Conclusions:
- Aberrant SRC-3 expression is a significant factor in the development of multiple human cancers.
- SRC-3 is important in both hormone-sensitive and hormone-insensitive cancers, underscoring its broad oncogenic potential.
- Further research into SRC-3's mechanisms may reveal new therapeutic targets for cancer treatment.
Related Concept Videos
Co-activators and Co-repressors
Co-activators and Co-repressors
Eukaryotic Transcription Activators
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...
RNA Polymerase II Accessory Proteins
RNA Polymerase II Accessory Proteins
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
